MA37380A1 - Lutte biologique - Google Patents
Lutte biologiqueInfo
- Publication number
- MA37380A1 MA37380A1 MA37380A MA37380A MA37380A1 MA 37380 A1 MA37380 A1 MA 37380A1 MA 37380 A MA37380 A MA 37380A MA 37380 A MA37380 A MA 37380A MA 37380 A1 MA37380 A1 MA 37380A1
- Authority
- MA
- Morocco
- Prior art keywords
- transcription factor
- expression
- effector gene
- regulatory element
- promoter
- Prior art date
Links
- 108091023040 Transcription factor Proteins 0.000 abstract 7
- 102000040945 Transcription factor Human genes 0.000 abstract 7
- 230000014509 gene expression Effects 0.000 abstract 7
- 239000012636 effector Substances 0.000 abstract 5
- 108090000623 proteins and genes Proteins 0.000 abstract 5
- 230000001105 regulatory effect Effects 0.000 abstract 3
- 238000011144 upstream manufacturing Methods 0.000 abstract 3
- 241000238421 Arthropoda Species 0.000 abstract 2
- 108091026890 Coding region Proteins 0.000 abstract 2
- 210000004602 germ cell Anatomy 0.000 abstract 2
- 108091026898 Leader sequence (mRNA) Proteins 0.000 abstract 1
- 230000021121 meiosis Effects 0.000 abstract 1
- 238000003908 quality control method Methods 0.000 abstract 1
- 238000013518 transcription Methods 0.000 abstract 1
- 230000035897 transcription Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/033—Rearing or breeding invertebrates; New breeds of invertebrates
- A01K67/0333—Genetically modified invertebrates, e.g. transgenic, polyploid
- A01K67/0337—Genetically modified Arthropods
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/033—Rearing or breeding invertebrates; New breeds of invertebrates
- A01K67/0333—Genetically modified invertebrates, e.g. transgenic, polyploid
- A01K67/0337—Genetically modified Arthropods
- A01K67/0339—Genetically modified insects, e.g. Drosophila melanogaster, medfly
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01M—CATCHING, TRAPPING OR SCARING OF ANIMALS; APPARATUS FOR THE DESTRUCTION OF NOXIOUS ANIMALS OR NOXIOUS PLANTS
- A01M99/00—Subject matter not provided for in other groups of this subclass
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- A01K2217/052—Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/20—Animal model comprising regulated expression system
- A01K2217/203—Animal model comprising inducible/conditional expression system, e.g. hormones, tet
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/20—Animal model comprising regulated expression system
- A01K2217/206—Animal model comprising tissue-specific expression system, e.g. tissue specific expression of transgene, of Cre recombinase
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/70—Invertebrates
- A01K2227/706—Insects, e.g. Drosophila melanogaster, medfly
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/02—Animal zootechnically ameliorated
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0393—Animal model comprising a reporter system for screening tests
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
- C07K2319/81—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor containing a Zn-finger domain for DNA binding
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/90—Vectors containing a transposable element
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/002—Vectors comprising a special translation-regulating system controllable or inducible
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Environmental Sciences (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Animal Husbandry (AREA)
- Animal Behavior & Ethology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Insects & Arthropods (AREA)
- Pest Control & Pesticides (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Catching Or Destruction (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
L'invention concerne un système d'expression génique de lignée germinale d'arthropode mâle approprié pour l'expression conditionnelle d'un gène effecteur dans une lignée germinale d'arthropode. Le système comprend une première unité d'expression renfermant un gène effecteur et un promoteur fonctionnellement relié audit gène effecteur ; et une seconde unité d'expression. La seconde unité comprend une séquence de codage pour un facteur de transcription et un élément de régulation amont relié fonctionnellement audit facteur de transcription, ce dernier étant capable d'agir sur le promoteur dans la première unité d'expression afin d'entraîner l'expression du gène effecteur. L'élément de régulation amont comprend un promoteur pour le facteur de transcription ; et un 5' utr adjacent à un site de départ de la séquence de codage du facteur de transcription. L'élément de régulation amont entraîne une expression suffisante du facteur de transcription de telle sorte que la protéine de facteur de transcription entraîne à son tour une transcription du gène effecteur avant la méiose. L'invention concerne également les utilisations du système, par exemple, dans des procédés de lutte biologique et de contrôle de qualité.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1203850.1A GB2500113A (en) | 2012-03-05 | 2012-03-05 | Arthropod male germline gene expression system |
PCT/EP2013/054417 WO2013131920A1 (fr) | 2012-03-05 | 2013-03-05 | Lutte biologique |
Publications (2)
Publication Number | Publication Date |
---|---|
MA37380A1 true MA37380A1 (fr) | 2016-05-31 |
MA37380B1 MA37380B1 (fr) | 2017-01-31 |
Family
ID=46003145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA37380A MA37380B1 (fr) | 2012-03-05 | 2014-09-26 | Expression d'un gène effecteur dans une lignée germinale d'arthropode |
Country Status (23)
Country | Link |
---|---|
US (2) | US9487801B2 (fr) |
EP (2) | EP3395949A1 (fr) |
JP (1) | JP6363023B2 (fr) |
CN (2) | CN104271747B (fr) |
AR (2) | AR091314A1 (fr) |
AU (2) | AU2013229578B2 (fr) |
BR (1) | BR112014021922B1 (fr) |
CA (1) | CA2866411A1 (fr) |
CL (1) | CL2014002369A1 (fr) |
CO (1) | CO7160024A2 (fr) |
CR (1) | CR20140439A (fr) |
CY (1) | CY1120531T1 (fr) |
ES (1) | ES2683039T3 (fr) |
GB (1) | GB2500113A (fr) |
GT (1) | GT201400188A (fr) |
MA (1) | MA37380B1 (fr) |
MX (1) | MX359468B (fr) |
MY (1) | MY169450A (fr) |
PE (1) | PE20142278A1 (fr) |
PH (1) | PH12014501993B1 (fr) |
SG (2) | SG10201702181PA (fr) |
WO (1) | WO2013131920A1 (fr) |
ZA (1) | ZA201406925B (fr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2404382B (en) | 2003-07-28 | 2008-01-30 | Oxitec Ltd | Pest control |
GB2443186A (en) | 2006-10-25 | 2008-04-30 | Oxitec Ltd | Expression system for mediating alternative splicing |
GB201303932D0 (en) | 2013-03-05 | 2013-04-17 | Oxitec Ltd | Muscle actin promoter |
WO2015105928A1 (fr) * | 2014-01-08 | 2015-07-16 | President And Fellows Of Harvard College | Activateurs de gènes guidés par l'arn |
GB2526867A (en) | 2014-06-05 | 2015-12-09 | Oxitec Ltd | Gene expression system |
WO2018029534A1 (fr) | 2016-08-12 | 2018-02-15 | Oxitec Ltd. | Gène spécifique du sexe à auto-limitation et procédés d'utilisation |
GB201810253D0 (en) * | 2018-06-22 | 2018-08-08 | Imperial Innovations Ltd | Gene drive |
GB201810256D0 (en) * | 2018-06-22 | 2018-08-08 | Imperial Innovations Ltd | Polynucleotide |
US20210324409A1 (en) * | 2018-08-14 | 2021-10-21 | Oxitec Limited | Self-Selecting Sterile Male Arthropods |
CN109105341A (zh) * | 2018-09-04 | 2019-01-01 | 安徽师范大学 | 一种用于防治斑翅果蝇的辐照不育方法 |
GB2579224A (en) * | 2018-11-26 | 2020-06-17 | Zyzzle Ltd | Apparatus for producing an improved animal population |
EP3660053A1 (fr) * | 2018-11-27 | 2020-06-03 | Fraunhofer Gesellschaft zur Förderung der Angewand | Systèmes d'expression multiprotéique conçus pour la lutte contre les parasites |
WO2020178822A1 (fr) * | 2019-03-05 | 2020-09-10 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) | Oiseaux à édition de génome |
CN114395018A (zh) * | 2021-12-31 | 2022-04-26 | 天津大学 | CifA和CifB突变蛋白用于调控胞质不相容性的用途 |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5180873A (en) | 1985-04-16 | 1993-01-19 | Dna Plant Technology Corporation | Transformation of plants to introduce closely linked markers |
GB8901677D0 (en) | 1989-01-26 | 1989-03-15 | Ici Plc | Hybrid seed production |
US5643776A (en) | 1988-11-01 | 1997-07-01 | The Regents Of The University Of California | Insect diagnostic and control compositions |
US5254801A (en) | 1990-12-03 | 1993-10-19 | Monsanto Company | Heterologous dominant conditional lethal gene which is a phosphonate monoester hydrolase and use thereof in plants |
GB9216151D0 (en) | 1992-07-29 | 1992-09-09 | Ici Plc | Containment of plant germplasm |
US6225121B1 (en) | 1992-09-14 | 2001-05-01 | Institute Of Molecular Biology And Biotechnology/Forth | Eukaryotic transposable element |
GB9313975D0 (en) | 1993-07-06 | 1993-08-18 | Sandoz Ltd | Improvements in or relating to organic compounds |
EG23907A (en) | 1994-08-01 | 2007-12-30 | Delta & Pine Land Co | Control of plant gene expression |
US5670353A (en) | 1994-08-25 | 1997-09-23 | Mycogen Plant Science, Inc. | Subgenomic promoter |
US5753434A (en) | 1995-02-10 | 1998-05-19 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for altering sexual behavior |
US5851796A (en) | 1995-06-07 | 1998-12-22 | Yale University | Autoregulatory tetracycline-regulated system for inducible gene expression in eucaryotes |
FR2737731B1 (fr) | 1995-08-07 | 1997-10-10 | Pasteur Institut | Sequence de retroelements naturels ou synthetiques ayant pour fonction de permettre l'insertion de sequences nucleotidiques dans une cellule eucaryote |
AUPN816196A0 (en) | 1996-02-19 | 1996-03-14 | Forbio Research Pty Ltd | Regulation of eukaryotic gene expression |
US5773697A (en) | 1996-04-23 | 1998-06-30 | Pioneer Hi-Bred International, Inc. | Genetic constructs and methods for producing fruits with very little or diminished seed |
EP0920521A1 (fr) | 1996-08-26 | 1999-06-09 | Genencor International, Inc. | IDENTIFICATION ET CLONAGE D'UN TRANSPOSON MOBILE ISSU D'$i(ASPERGILLUS) |
JP2001501824A (ja) * | 1996-10-01 | 2001-02-13 | ユニバーシティー オブ ジョージア リサーチ ファウンデーション,インコーポレイテッド | 昆虫特異的ダニ毒素遺伝子を発現する生物学的昆虫防除剤、方法および組成物 |
US7135608B1 (en) | 1997-08-28 | 2006-11-14 | The Salk Institute For Biological Studies | Site-specific recombination in eukaryotes and constructs useful therefor |
US6338040B1 (en) | 1999-02-12 | 2002-01-08 | Agren, Inc. | Method for delaying the development in pest species of resistance to control techniques, using insurance to encourage correct uses of refuges |
AU5642800A (en) | 1999-06-01 | 2000-12-18 | Inserm | Method of transposon-mediated mutagenesis in the nematode LTiGTcaenorhabditisLT/iGT LTiGTelegansLT/iGT |
GB2355459B (en) | 1999-11-29 | 2001-09-26 | Isis Innovation | A dominant conditional lethal genetic system |
WO2001059088A2 (fr) | 2000-02-11 | 2001-08-16 | Queen Mary & Westfield College | Vecteur |
US20030150007A1 (en) | 2000-03-21 | 2003-08-07 | Charalambos Savakis | Method of generating transgenic organisms using transposons |
US20060057553A1 (en) | 2000-05-30 | 2006-03-16 | Estuardo Aguilar-Cordova | Chimeric viral vectors for gene therapy |
US6962810B2 (en) | 2000-10-31 | 2005-11-08 | University Of Notre Dame Du Lac | Methods and compositions for transposition using minimal segments of the eukaryotic transformation vector piggyBac |
EP1339863A2 (fr) | 2000-12-05 | 2003-09-03 | Wisconsin Alumni Research Foundation | Procedes de transposition double destines a la manipulation d'acides nucleiques |
ITRM20010120A1 (it) | 2001-03-08 | 2002-09-08 | Univ Napoli Federico Ii | Gene cctra come strumento per produrre progenie di soli maschi nella mosca mediterranea ceratitis capitata. |
FR2825579B1 (fr) | 2001-06-11 | 2004-07-23 | Rhobio | Methode d'obtention de plante monocotyledone contenant un gene d'interet sans sequence auxiliaire etrangere |
DE10251918A1 (de) | 2002-11-08 | 2004-05-19 | Horn, Carsten, Dipl.-Biochem. Dr. | Systeme zur Erzeugung stabiler genomischer Transgen-Insertionen |
GB2402675B (en) | 2003-05-12 | 2008-02-20 | Oxitec Ltd | Resistance dilution |
AU2004245598B2 (en) | 2003-06-10 | 2009-01-08 | National Research Council Of Canada | A coumermycin/novobiocin-regulated gene expression system |
GB2403475B (en) | 2003-07-01 | 2008-02-06 | Oxitec Ltd | Stable integrands |
GB2404382B (en) * | 2003-07-28 | 2008-01-30 | Oxitec Ltd | Pest control |
US7569362B2 (en) | 2004-03-15 | 2009-08-04 | Biogen Idec Ma Inc. | Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing |
US7563601B1 (en) | 2005-06-01 | 2009-07-21 | City Of Hope | Artificial riboswitch for controlling pre-mRNA splicing |
EP3159414A1 (fr) | 2006-02-10 | 2017-04-26 | Oxitec Limited | Système d'expression |
GB2443186A (en) | 2006-10-25 | 2008-04-30 | Oxitec Ltd | Expression system for mediating alternative splicing |
JP2008067678A (ja) * | 2006-09-15 | 2008-03-27 | Kyushu Institute Of Technology | 昆虫の減数分裂期における染色体標的組換え誘導方法 |
US8198079B2 (en) * | 2007-04-26 | 2012-06-12 | Merck Sharp & Dohme Corp. | Synthetic expression vectors for insect cells |
WO2009016627A1 (fr) * | 2007-07-30 | 2009-02-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Peptides sexuels résistant à une dégradation protéolytique et leur utilisation dans la lutte biologique contre les insectes |
US20110088105A1 (en) * | 2008-03-20 | 2011-04-14 | Wimmer Ernst A | Development stage-specific lethality system for insect population control |
KR20110029156A (ko) | 2008-06-27 | 2011-03-22 | 메뤼스 베.페. | 항체 생산 비-인간 포유동물 |
CN102939383B (zh) * | 2009-12-30 | 2015-04-29 | 先锋国际良种公司 | 用于靶向多核苷酸修饰的方法和组合物 |
-
2012
- 2012-03-05 GB GB1203850.1A patent/GB2500113A/en not_active Withdrawn
-
2013
- 2013-03-05 CN CN201380023783.9A patent/CN104271747B/zh active Active
- 2013-03-05 AR ARP130100723 patent/AR091314A1/es active IP Right Grant
- 2013-03-05 SG SG10201702181PA patent/SG10201702181PA/en unknown
- 2013-03-05 JP JP2014560338A patent/JP6363023B2/ja not_active Expired - Fee Related
- 2013-03-05 EP EP18163791.9A patent/EP3395949A1/fr not_active Withdrawn
- 2013-03-05 US US14/383,515 patent/US9487801B2/en active Active
- 2013-03-05 SG SG11201405481SA patent/SG11201405481SA/en unknown
- 2013-03-05 AU AU2013229578A patent/AU2013229578B2/en active Active
- 2013-03-05 WO PCT/EP2013/054417 patent/WO2013131920A1/fr active Application Filing
- 2013-03-05 BR BR112014021922-2A patent/BR112014021922B1/pt active IP Right Grant
- 2013-03-05 ES ES13711848T patent/ES2683039T3/es active Active
- 2013-03-05 PE PE2014001359A patent/PE20142278A1/es active IP Right Grant
- 2013-03-05 CA CA2866411A patent/CA2866411A1/fr not_active Abandoned
- 2013-03-05 EP EP13711848.5A patent/EP2823047B1/fr active Active
- 2013-03-05 CN CN201710958978.2A patent/CN108018309A/zh active Pending
- 2013-03-05 MX MX2014010712A patent/MX359468B/es active IP Right Grant
- 2013-03-05 MY MYPI2014002574A patent/MY169450A/en unknown
-
2014
- 2014-09-05 PH PH12014501993A patent/PH12014501993B1/en unknown
- 2014-09-05 GT GT201400188A patent/GT201400188A/es unknown
- 2014-09-05 CL CL2014002369A patent/CL2014002369A1/es unknown
- 2014-09-22 ZA ZA2014/06925A patent/ZA201406925B/en unknown
- 2014-09-23 CR CR20140439A patent/CR20140439A/es unknown
- 2014-09-26 MA MA37380A patent/MA37380B1/fr unknown
- 2014-10-02 CO CO14218631A patent/CO7160024A2/es unknown
-
2016
- 2016-09-21 US US15/272,348 patent/US20170009253A1/en not_active Abandoned
-
2017
- 2017-10-18 AU AU2017248469A patent/AU2017248469A1/en not_active Abandoned
-
2018
- 2018-08-07 CY CY20181100819T patent/CY1120531T1/el unknown
-
2023
- 2023-02-17 AR ARP230100383A patent/AR128556A2/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA37380A1 (fr) | Lutte biologique | |
CY1122435T1 (el) | Ποντικοι με εξανθρωπισμενη καθολικη ελαφρια αλυσιδα | |
ES2525477T3 (es) | Anticuerpos anti-factor D humanizados | |
CY1122036T1 (el) | Μη ανθρωπινα ζωα που εκφραζουν αντισωματα τα οποια εχουν μια κοινη ελαφρια αλυσιδα | |
PE20120079A1 (es) | Moleculas de anticuerpos mejoradas | |
PE20110802A1 (es) | Un anticuerpo antagonista de pcsk9 | |
AR083747A1 (es) | Anticuerpos anti-il-23 | |
CY1115700T1 (el) | Αντισωματα και ανοσοσυζευγματα αντι-cd79b και μεθοδοι χρησης | |
LTPA2016030I1 (lt) | Dauginės mielomos, naudojant kombinuotas terapijas, pagrįstas anti-CS1 antikūnais, gydymo būdai | |
UY30925A1 (es) | Proteinas de fusion de inmunoglobulina y metodos de elaboracion | |
CU23809A3 (es) | Anticuerpo específico prlr | |
AR056292A1 (es) | Sistema y metodo para operar uno o mas dispensadores de combustible | |
CR10325A (es) | Diagnosticos y tratamientos para tumores | |
GT200800098A (es) | Anticuerpos anti mn y metodos para su utilización | |
EP1912674B8 (fr) | Molécules d'anticorps fv à chaîne unique bispécifiques et procédés d'utilisation de celles-ci | |
WO2008134724A3 (fr) | Procédés d'administration d'anticorps anti-il-5 | |
MY191348A (en) | Antibodies and derivatives thereof | |
PE20140806A1 (es) | Anticuerpos anti-factor d humanizados y sus usos | |
DE602005018325D1 (de) | Antikörper mit korrigierten cdr | |
NO20090047L (no) | Anti-DLL4-antistoffer og fremgangsmater for anvendelse av disse | |
NO20063767L (no) | Antistoffer mot clostridium difficile toksiner og anvendelser derav | |
AR062213A1 (es) | Anticuerpos dirigidos contra (alfa v beta 6) y usos de los mismos | |
CY1116306T1 (el) | Συλλογες γενετικων πακετων που αποτελουνται απο νεα hc cdr1, cdr2, και cdr3 και νεα lc cdr1, cdr2 cdr3 σχεδια | |
CL2021000066A1 (es) | Variantes de anticuerpos anti-cd38 y sus usos | |
CL2008003790A1 (es) | Metodo para purificar anticuerpo cd20 de una mezcla que comprende cristalizar el anticuerpo cd20 y recuperar el anticuerpo cd20 de la mezcla. |